Analysed ASTELLAS PHARMA INC (ALPMF:OTCMKTS) News Sources
Dyno Therapeutics Announces Capsid License Exercised by Astellas for Skeletal Muscle-Targeted Gene Delivery, Validating AI-Powered Technology for Biological Sequence Design
08-04-2026
yahoo.com
Pfizer aims for wider use of PARP drug in prostate cancer with new data
19-03-2026
biopharmadive.com
Pfizer Inc. (PFE) and Astellas Report Positive Phase 3 EV-304 Results for PADCEV Plus Keytruda in Bladder Cancer
04-03-2026
yahoo.com
What is the current price of ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The current price of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is $17.3.
ASTELLAS PHARMA INC (ALPMF:OTCMKTS) absolute price change since previous trading day?
The absolute price change of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) since the previous trading day is $1.72.
ASTELLAS PHARMA INC (ALPMF:OTCMKTS) percentage price change since previous trading day?
The percentage price change of ASTELLAS PHARMA INC (ALPMF:OTCMKTS) since the previous trading day is 11.0398%.
What is the most recent average sentiment score for ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The most recent average sentiment score for ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is 81 out of 100.
What is the most recent average sentiment for ASTELLAS PHARMA INC (ALPMF:OTCMKTS)?
The most recent sentiment for ASTELLAS PHARMA INC (ALPMF:OTCMKTS) is .
SEC-8K** Filing Available For ASTELLAS PHARMA INC (ALPMF:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.